EPW
TEVA icon

Evergreen Private Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Evergreen Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-359
Closed -$6.02K – 292
2025
Q2 		$6.02K Hold
359
– – ﹤0.01% 173
2025
Q1 		$5.52K Buy
+359
New +$6.41K ﹤0.01% 162

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Evergreen Private Wealth's TEVA Position: Q3 2025 in Review

Evergreen Private Wealth sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 359 shares — an estimated $6.02K sold.

Evergreen Private Wealth first reported a position in TEVA in Q1 2025 and held it in 2 quarters. The position peaked at $6.02K in Q2 2025. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Evergreen Private Wealth reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Evergreen Private Wealth sold 359 Teva Pharmaceuticals shares in Q3 2025, an estimated $6.02K.
  • Evergreen Private Wealth first reported a position in Teva Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Evergreen Private Wealth's Teva Pharmaceuticals position peaked at $6.02K in Q2 2025.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Evergreen Private Wealth's 13F filing for Q3 2025, filed 24 Oct 2025.